🇬🇧 Unravelling the mechanisms of radiotherapy response and development of biomarkers for radiotherapy treatment stratification » Luxembourg Institute of Health
Starseite » Veranstaltungen » 🇬🇧 Unravelling the mechanisms of radiotherapy response and development of biomarkers for radiotherapy treatment stratification

Bitte beachten Sie, dass der Inhalt nur auf Englisch verfügbar ist.

🇬🇧 Unravelling the mechanisms of radiotherapy response and development of biomarkers for radiotherapy treatment stratification

26/02/2024 11:00 an 13:30
  • Lecture Series Cancer Research

Speaker

Prof Mahvash
Tavassoli

Team Leader and Head of Molecular Oncology Department, King’s College London

Abstract

Radiation therapy remains an important component of cancer treatment with approximately 50% of all cancer patients receiving radiation therapy during their course of therapy; it contributes towards 40% of curative treatment for cancer. In general, about 50% of patients are resistant to RT and so far, it has been unclear which tumours will develop resistance to RT, excluding the functional adaptation of the treatment to the individual patient’s risk. Radioresistance may be intrinsic, or acquired, and may be direct (tumour-cell autonomous) or indirect, mediated by RT-mediated changes to the tumour microenvironment (TME) such as cellular and/or extracellular matrix (ECM) changes to the stroma and tumour hypoxia. Decades have been spent to improve the radiotherapy outcome without much success. Personalised RT can improve treatment outcomes. My lab is studying the mechanisms of radiotherapy response/resistance in head and neck cancer for which RT is the main treatment modality. Our research aims to identify radiotherapy genetic signature and we have established relevant 3D tumour models comprising the component of TME to identify the causes of differential patients’ response to RT. The findings will enable the future treatment stratification of patients and will identify new therapeutic targets and strategies that can mitigate the side effects of RT while maintaining or improving treatment efficacy.


Host

Department of Cancer Research – LIH
University of Luxembourg

Responsible Scientist
Bassam
Janji
Thomas
Sauter

*Please note that registration is mandatory by sending an email to siu-thinh.ho@lih.lu

LOCATION

CHL – Centre
Room Amphitheatre

4, rue Nicolas Ernest Barblé
L-1210 Luxembourg (Belair)

LECTURE: 11:00am – 12:00pm

MEET & EAT*

12:30pm – 13:30pm

DoCR
Room McClintock (2nd floor)

6A, rue Nicolas-Ernest Barblé
L-1210 Luxembourg

Light lunch provided

Supported by:

Teilen auf

Datenschutz

Lesen Sie mehr über den „Datenschutzhinweis: Verarbeitung personenbezogener Daten im Rahmen der Organisation von Veranstaltungen“.